Share on StockTwits

Johnson & Johnson (NYSE:JNJ) has earned an average rating of “Hold” from the seventeen brokerages that are presently covering the company, AmericanBankingNews.com reports. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and six have issued a buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $98.00.

Shares of Johnson & Johnson (NYSE:JNJ) traded down 0.19% on Thursday, hitting $101.55. 735,070 shares of the company’s stock traded hands. Johnson & Johnson has a 52-week low of $85.50 and a 52-week high of $106.74. The stock’s 50-day moving average is $102.9 and its 200-day moving average is $98.60. The company has a market cap of $286.4 billion and a price-to-earnings ratio of 18.81.

Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings data on Tuesday, July 15th. The company reported $1.66 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.54 by $0.12. The company had revenue of $19.50 billion for the quarter, compared to the consensus estimate of $18.86 billion. During the same quarter in the prior year, the company posted $1.48 earnings per share. The company’s quarterly revenue was up 9.1% on a year-over-year basis. On average, analysts predict that Johnson & Johnson will post $5.92 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 9th. Investors of record on Tuesday, August 26th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 2.75%. The ex-dividend date is Friday, August 22nd.

A number of analysts have recently weighed in on JNJ shares. Analysts at Jefferies Group reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Monday. They now have a $108.00 price target on the stock, down previously from $114.00. Separately, analysts at Citigroup Inc. reiterated a “buy” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $122.00 price target on the stock, up previously from $117.00. Finally, analysts at Deutsche Bank reiterated a “hold” rating on shares of Johnson & Johnson in a research note on Wednesday, July 16th. They now have a $107.00 price target on the stock, up previously from $102.00.

Johnson & Johnson is a holding company. The Company is engaged in the research and development, manufacture and sale of a broad range of products in the health care field.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.